Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?
Үндсэн зохиолчид: | Conrad, N, McInnes, IB, Mcmurray, JJV, Sattar, N |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
BMJ Publishing
2022
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Review of the European League Against Rheumatism (EULAR) guidelines considered in 2018
-н: T. V. Beketova
Хэвлэсэн: (2019-05-01) -
ACCORDING TO THE MATERIALS OF THE 2015/2016 NEW EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) GUIDELINES FOR REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY ARTHRITIS: GENERAL CHARACTERIZATION AND DISCUSSION PROBLEMS
-н: T. V. Popkova, зэрэг
Хэвлэсэн: (2018-07-01) -
According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
-н: T. V. Popkova, зэрэг
Хэвлэсэн: (2019-11-01) -
EULAR recommendations on the management of systemic qlucocorticoid therapy in Rheumatic diseases
-н: Y. Jakods, зэрэг
Хэвлэсэн: (2016-05-01) -
Cardiovascular risk in systemic autoimmune diseases – authors' reply
-н: Conrad, N, зэрэг
Хэвлэсэн: (2023)